Skip to content

Resolute Integrity™ RSINT27518UXRecalls & reported problems

Medtronic, Inc. · Stent RSINT27518UX MicroTrac 2.75X18RX · Class 3 · Implant

All models of Resolute Integrity (52)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169037564), received between Dec 20, 2016 and Dec 20, 2016 — classified as 1 malfunction.

The most frequently reported specific device problem is “Material Deformation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Material Deformation1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 20, 2016Material Deformation; Material Deformation

    AN ATTEMPT WAS BEING MADE TO USE A RESOLUTE INTEGRITY DRUG ELUTING STENT IN A HEAVILY CALCIFIED LAD LESION. THE DEVICE WAS INSPECTED BEFORE USE AND NO ISSUES WERE REPORTED. THE LESION WAS PRE-DILATED. RESISTANCE WAS NOT NOTED WHILE GETTING TO THE LESION AND EXCESSIVE FORCE WAS NOT USED. WHEN ADVANCEMENT BECAME A LITTLE HARDER THE DEVICE WAS RETRACTED. STENT DEFORMATION WAS THEN NOTICED. THE PROCEDURE WAS COMPLETED USING ANOTHER STENT. NO PATIENT INJURY REPORTED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6188377 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page